In a murine model of pancreatic cancer, administration of a CEACAM6-specific monoclonal antibody conjugated with immunotoxin increases tumor apoptosis and decreases tumor growth (46). This evidence concerns the gene CEACAM6 and familial pancreatic carcinoma.